IMVT Stock-Based Compensation
Immunovant Inc · Stock-Based Compensation
IMVT Stock-Based Compensation
Latest reported$50.99Mperiod ending
IMVT TTM Stock-Based Comp (-$320.69K → $50.99M)
TTM stock-based compensation
High-resolution chart · PNG
IMVT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 50,988,000 | |
| 55,724,000 | |
| 56,270,000 | |
| 55,207,000 | |
| 54,542,000 | |
| 49,487,000 | |
| 47,479,000 | |
| 46,047,000 | |
| 43,883,000 | |
| 41,116,000 | |
| 38,983,000 | |
| 37,669,000 | |
| 35,297,000 | |
| 32,296,000 | |
| 36,613,000 | |
| 37,866,000 | |
| 38,070,000 | |
| 34,244,000 | |
| 27,869,000 | |
| 17,710,000 | |
| 12,710,000 | |
| 12,830,000 | |
| 9,182,000 | |
| 9,183,414 | |
| 5,825,551 | |
| 1,845,123 | |
| -320,688 | |
| -85,630 | |
| 394,028 | |
| 748,735 |